Aura Biosciences Receives FDA Fast Track Designation for Belzupacap Sarotalocan for the Treatment of Non-Muscle Invasive Bladder Cancer

CanariaBio reaches 50% target enrolment for Phase III clinical study of oregovomab to treat front-line advanced ovarian cancer

Ascentage Pharma's APG-5918 receives approval from FDA for first-in-human study

Trastuzumab Deruxtecan Recommended for Approval in the EU by CHMP for Patients with HER2 Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen

SwanBio Presents Design of Innovative Natural History Study Aimed to Evolve Understanding of Adrenomyeloneuropathy and Inform Future Treatments

Lynparza Receives Positive Opinion from EU CHMP as Adjuvant Treatment for Germline BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer

First Two Patients Dosed in Phase 1b/2a Study of BX004 for Treatment of Chronic Respiratory Infections in Patients with Cystic Fibrosis

US FDA Approves Prestige Biopharma's IND for Phase 1/2a Trial of First-in-Class Pancreatic Cancer Treatment, PBP1510

Bayer opens new research centre in Boston-Cambridge

Soligenix's SGX302 IND clinical trial application receives US FDA approval

United States Patent and Trademark Office grants new patent for Chemomab Therapeutics' CM-101

BioLineRx signs collaboration agreement with GenFleet Therapeutics

IDEAYA Biosciences selects potential first-in-class Pol Theta Helicase development candidate

Inscopix Launches New Integrated Miniscope-Behavioral Platform and Co-marketing Collaboration with Noldus

US FDA Places Partial Clinical Hold On Nuvation Bio Phase 1 Study of NUV-422 in Solid Tumors